Multicomponent Agents for Prevention and Treatment of Digestive Diseases

Introduction. In recent years, there has been a steady increase in gastroenterological diseases in many countries due to adverse environmental conditions and unsustainable nutrition. Diseases of digestive organs are not only chronic, but also combined, and varieties of synthetic drugs are widely used in therapy. The range of official multicomponent plant collections recommended in the therapy of diseases of the digestive system is limited, and their disadvantage is especially felt in the treatment of chronic hepatitis, gastric ulcer, cholecystitis.

Aim. Search and creation of new multicomponent agents for prevention and complex treatment of digestive system diseases.

Materials and methods. The objects of the study were developed multi-component means: «Pentafit», «Octafit», «Hexafit». To assess the pharmacotherapeutic effect of the developed agents «Pentafit» hepatoprotective activity studied in experimental models tetrachloromethane and D-galactosamine hepatitis, «Octafit» gastroprotective activity studied in models of acute aspirins, neurogenic and chronic butadione ulcer, сholeretic activity of «Hexafit» as studied in models of experimental cholecystitis and toxic liver damage using laboratory animals. The results of the studies processed statistically using the Statistica 10 program.

Results and discussion. Based on the obtained data, the general patterns in molecular biological action of the studied multicomponent agents revealed, which consist in their ability to inhibit the free radical oxidation of lipids and stabilize the biological membranes of gastric cells and organs of the hepatobiliary system. «Pentafit» profitably distinguished by its multilateral nature of influence on the functional state and structure of the organs of the liver. «Octafit» provides accelerated healing and restoration of damaged structures of functional systems of the stomach. «Hexafit» secreted by the polyvalent spectrum of action in case of damage to the hepatobiliary system.

Conclusion. Developed multicomponent drugs will expand the register of medicines of plant origin of domestic production for the prevention and treatment of digestive diseases.

1. Lubsandorzhieva P.-N. B. Development and standardization of herbal medicines for the treatment and prevention of digestive diseases. Ulan-Udeh: BNC SO RAN, 2016. 280 р. (In Russ.).

2. Kharrazian D. et al. Gastrointestinal Diseases: Recent Research and Commentary (translated by Bochagov V.). Available at: applied-kinesiology.ru/book/107 (accessed 06.07.2020).

3. State Register of Medicines. Available at: https://grls.rosminzdrav.ru/ (accessed 07.07.2020). (In Russ.).

4. Lubsandorzhieva P. B., Ferubko E. V., Dargaeva T. D. Methodological approach to the creation of multicomponent herbal medicines for the treatment of digestive diseases. Tradicionnaya medicina = Traditional medicine. 2018;3:35-39. (In Russ.).

5. Guidelines for preclinical studies of drugs. Part 1. M.: Grif i K, 2012. 944 р. (In Russ.).

6. Borovikov V. P. A popular introduction to modern data analysis in the STATISTICA system. M.: Goryachaya liniya. Telekom, 2014. 288 р. (In Russ.).

7. Ferubko E. V., Nikolaev S. M., Dargaeva T. D. Results of experimental studies of plant extract on a model of toxic liver damage in an animal experiment. Tradicionnaya medicina = Traditional medicine. 2019;3:45-49. (In Russ.).

8. Ferubko E. V., Nikolaev S. M., Pupykina K. A., Dargaeva T. D. Estimation of antiulcerous effect of multicomponent plant extract in experiment. Yakut Medical Journal. 2019;1:45-47.

9. Ferubko E. V., Nikolaev S. M., Dargaeva T. D., Rendyuk T. D. Correction of toxic liver damage with a multicomponent herbal extract in an animal experiment. Pharmacognosy Journal. 2020;1 2(1):168-172.

10. Nikolaev S. M. Phytopharmacotherapy and disease phytopharma-coprophylaxis. Ulan-Udeh: BGU, 2012. 286 р. (In Russ.)